|
0.25 Percent Bupivacaine Hydrochloride Injection, USP by Hospira: Recall - Particulate Matter
|
08/05/2016
|
|
50 Percent Magnesium Sulfate Injection, USP by Hospira: Recall - Presence Of Particulate Matter
|
04/14/2016
|
|
5 Percent Dextrose Injection USP in PAB Container by B. Braun Medical: Recall - Leakage and/or Particulate Matter
|
03/29/2016
|
|
0.9 Percent Sodium Chloride Solution for Irrigation by Baxter: Recall - Presence of Particulate Matter
|
02/18/2016
|
|
Amikacin Sulfate Injection USP 500 mg/2 mL (250 mg/mL) and 1 Gram/4 mL (250 mg/mL) Vials by Teva: Recall - Glass Particulate Matter
|
08/03/2016
|
|
Amikacin Sulfate Injection USP, 1 gram/4mL (250 mg/mL) Vials by Teva: Recall - Glass Particulate Matter
|
03/10/2016
|
|
Aripiprazole (Abilify, Abilify Maintena, Aristada): Drug Safety Communication - FDA Warns About New Impulse-control Problems
|
05/03/2016
|
|
Baxter IV Solutions (Select Lots): Recall - Potential for Leaking Containers and Particulate Matter
|
01/27/2016
|
|
Baxter IV Solutions: Recall - Potential Presence of Particulate Matter
|
01/05/2016
|
|
BiCNU (carmustine for injection): FDA Alert - Counterfeit Product Discovered in Some Foreign Countries
|
05/13/2016
|
|
Brintellix (vortioxetine): Drug Safety Communication - Brand Name Change to Trintellix, to Avoid Confusion With Antiplatelet Drug Brilinta (ticagrelor)
|
05/02/2016
|
|
Canagliflozin (Invokana, Invokamet): Drug Safety Communication - Clinical Trial Results Find Increased Risk of Leg and Foot Amputations
|
05/18/2016
|
|
Canagliflozin (Invokana, Invokamet) and Dapagliflozin (Farxiga, Xigduo XR): Drug Safety Communication - Strengthened Kidney Warnings
|
06/14/2016
|
|
Cetylev (acetylcysteine) Effervescent Tablets for Oral Solution by Arbor Pharmaceuticals: Recall - Inadequate Seal of Blister Pack
|
08/18/2016
|
|
Chantix (varenicline) and Zyban (bupropion): Drug Safety Communication - Mental Health Side Effects Revised
|
12/16/2016
|
|
Children's Guaifenesin Grape Liquid and Guaifenesin DM Cherry Liquid by Perrigo Company: Recall - Potential Defect with Dosage Cup
|
01/13/2016
|
|
Diabetes Medications Containing Saxagliptin and Alogliptin: Drug Safety Communication - Risk of Heart Failure
|
04/05/2016
|
|
Direct-Acting Antivirals for Hepatitis C: Drug Safety Communication - Risk of Hepatitis B Reactivating
|
10/04/2016
|
|
Family Care Eye Wash by United Exchange Corp: Recall - Microbial Contamination
|
09/08/2016
|
|
Fluoroquinolone Antibacterial Drugs for Systemic Use: Drug Safety Communication - Warnings Updated Due to Disabling Side Effects
|
07/26/2016
|
|
Fluoroquinolone Antibacterial Drugs: Drug Safety Communication - FDA Advises Restricting Use for Certain Uncomplicated Infections
|
05/12/2016
|
|
Eye Wash/Eye Irrigating Solutions Distributed by Major Pharmaceuticals and Rugby Laboratories: Recall - Microbial Contamination
|
09/07/2016
|
|
Eye Drops: FDA Statement - Potential Risk of Loose Safety Seals
|
03/15/2016
|
|
Eyesaline Eyewash by Honeywell: Recall - Microbial Contamination
|
08/22/2016
|
|
Fluconazole (Diflucan): Drug Safety Communication - FDA Evaluating Study Examining Use of Oral Fluconazole (Diflucan) in Pregnancy
|
04/26/2016
|
|
Fluconazole Injection, USP, (in 0.9 Percent Sodium Chloride) 200mg per 100ml: Recall - Elevated Impurity
|
03/05/2016
|
|
General Anesthetic and Sedation Drugs: Drug Safety Communication - New Warnings for Young Children and Pregnant Women
|
12/14/2016
|
|
GlucaGen HypoKit (glucagon [rDNA origin] for injection) by Novo Nordisk Inc: Recall - Detached Needles on Syringe
|
09/09/2016
|
|
HCG and Sermorelin by Talon Compounding Pharmacy: Recall - Lack of Sterility Assurance
|
07/22/2016
|
|
Human and Animal Sterile Drug Products by I.V. Specialty: FDA Alert - Lack of Sterility Assurance
|
03/09/2016
|
|
Hyoscyamine Sulfate 0.125mg by Virtus Pharmaceuticals: Recall - Superpotent and Subpotent Test Results
|
09/15/2016
|
|
Lamotrigine Orally Disintegrating Tablet 200 mg by Impax: Recall - Incorrect Labeling of Blister Cards
|
08/29/2016
|
|
Licorice Coughing Liquid OTC Cough Syrup by Ma Ying Long Pharmaceutical Group: CDER Alert - Contains Unidentified Morphine
|
01/16/2016
|
|
Loperamide (Imodium): Drug Safety Communication - Serious Heart Problems With High Doses From Abuse and Misuse
|
06/07/2016
|
|
Magnesium Sulfate in Water for Injection by Hospira: Recall - Incorrect Barcode Labeling on the Primary Container
|
01/06/2016
|
|
Metformin-containing Drugs: Drug Safety Communication - Revised Warnings for Certain Patients With Reduced Kidney Function
|
04/08/2016
|
|
Morphine Sulfate 0.5 mg/mL Preservative Free in 0.9 percent Sodium Chloride by Pharmakon Pharmaceuticals: Recall - Super-potent Product
|
02/17/2016
|
|
Noxafil (posaconazole): Drug Safety Communication - Dosing Errors when Switching between Different Oral Formulations; Label Changes Approved
|
01/04/2016
|
|
Olanzapine: Drug Safety Communication - FDA Warns About Rare But Serious Skin Reactions
|
05/10/2016
|
|
Opioid Pain or Cough Medicines Combined With Benzodiazepines: Drug Safety Communication - FDA Requiring Boxed Warning About Serious Risks and Death
|
08/31/2016
|
|
Opioid Pain Medicines: Drug Safety Communication - New Safety Warnings Added to Prescription Opioid Medications
|
03/22/2016
|
|
Oral Liquid Docusate Sodium by PharmaTech : Recall - Contaminated with B. Cepacia
|
07/16/2016
|
|
Over-the-Counter Antacid Products Containing Aspirin: FDA Drug Safety Communication - Serious Bleeding Risk
|
06/06/2016
|
|
Oxacillin for Injection, USP, 10g by Sagent: Recall - Iron Oxide Particulate Matter
|
08/19/2016
|
|
Liquid Drug and Dietary Supplement Products by PharmaTech: Recall - Risk of Product Contamination
|
08/09/2016
|
|
PharMEDium Sterile Preparations Compounded With a Single Recalled Lot of Fresenius Kabi Sensorcaine-MPF (bupivacaine HCl): Recall - Presence of Glass Particulate Matter
|
05/09/2016
|
|
Pioglitazone-containing Medicines: Drug Safety Communication - Updated FDA Review, Increased Risk of Bladder Cancer
|
12/12/2016
|
|
Compounded Products by Reliable Drug Pharmacy: Recall - Potential for Mislabeling and Lack of Quality Assurance
|
03/28/2016
|
|
Sensorcaine-MPF (bupivacaine HCl) by Fresenius Kabi: Recall - Presence of Particulate Matter
|
04/26/2016
|
|
Sodium Bicarbonate Injection, USP by Hospira: Recall - Particulate Matter
|
03/21/2016
|
|
Sterile Drug Products by Cantrell Drug Company: Recall - Lack of Sterility Assurance
|
11/21/2016
|
|
Sterile Drug Products by Medaus Pharmacy: FDA Alert - Lack of Sterility Assurance
|
04/01/2016
|
|
Sterile Drug Products from Pharmakon Pharmaceuticals: Recall - Lack of Sterility Assurance
|
04/16/2016
|
|
Syrspend SF and Syrspend SF Grape Suspending Agents by Fagron: FDA Alert - Microbial Contamination with Yeast
|
02/10/2016
|
|
Testosterone and Other Anabolic Androgenic Steroids (AAS): FDA Statement - Risks Associated With Abuse and Dependence
|
10/25/2016
|
|
Tri-Coast Pharmacy Sterile Products: Recall - Lack of Sterility Assurance
|
11/21/2016
|
|
Unexpired Sterile Human and Animal Compounded Products by Abbott's Compounding Pharmacy: Recall - Lack of Sterility Assurance
|
01/16/2016
|
|
Well Care Compounding Pharmacy Sterile Compounded Products: Recall - Lack Of Sterility Assurance
|
05/18/2016
|
|
Sterile Products by Wells Pharmacy Network: Recall - Concern for Lack of Sterility Assurance
|
09/22/2016
|
|
Zecuity (sumatriptan) Migraine Patch: Drug Safety Communication - FDA Evaluating Risk of Burns and Scars
|
06/02/2016
|